Compounds > trimethoprim--sulfamethoxazole-drug-combination

trimethoprim--sulfamethoxazole-drug-combination and Lipodystrophy

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Lipodystrophy* in 1 studies

Other Studies

1 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Lipodystrophy

ArticleYear
Conference news at a glance.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 1998, Volume: 10, Issue:5

    The 12th World AIDS Conference in Geneva provided evidence that STD prophylaxis/treatment does not reduce HIV transmission. New guidelines for antiretroviral therapy in terms of when to treat and when to change are also presented. Research findings and practical applications are also provided for the following areas: HIV therapeutic monitoring, immune reconstitution, prevention, TMP-SMX prophylaxis, lipodystrophy, serum lipid changes, and diabetes.

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Diabetes Complications; Drug Therapy, Combination; HIV Infections; Humans; Lipids; Lipodystrophy; Managed Care Programs; Practice Guidelines as Topic; Sexually Transmitted Diseases; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda; Viral Load

1998